Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
W.W. Grainger
GWW
$60.8B
| $185M | 0.05% |
518,061
+192,292
| +59% | +$66.2M |
2013 Q2
21 quarters
|
|
377
Brixmor Property Group
BRX
$8.38B
| $184M | 0.05% |
10,528,243
+885,944
| +9% | +$15.7M |
2013 Q4
19 quarters
|
|
378
Carlyle Group
CG
$13.7B
| $183M | 0.05% |
8,131,576
+619,635
| +8% | +$14.6M |
2013 Q2
21 quarters
|
|
379
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.4B
| $183M | 0.05% |
3,112,858
+179,832
| +6% | +$10.4M |
2016 Q1
10 quarters
|
|
380
Invesco Large Cap Value ETF
PWV
$1.83B
| $182M | 0.05% |
4,871,681
-159,380
| -3% | -$5.93M |
2013 Q2
21 quarters
|
|
381
Edwards Lifesciences
EW
$49.1B
| $182M | 0.05% |
3,132,327
-856,047
| -21% | -$41.9M |
2013 Q2
21 quarters
|
|
382
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.08B
| $182M | 0.05% |
2,289,768
-34,157
| -1% | -$2.72M |
2013 Q2
21 quarters
|
|
383
IQVIA
IQV
$42.8B
| $181M | 0.05% |
1,392,583
+177,638
| +15% | +$21.3M |
2013 Q2
21 quarters
|
|
384
Regency Centers
REG
$13.2B
| $180M | 0.05% |
2,783,960
-423,993
| -13% | -$27M |
2013 Q2
21 quarters
|
|
385
TE Connectivity
TEL
$63.2B
| $179M | 0.04% |
2,038,145
+290,638
| +17% | +$26.7M |
2013 Q2
21 quarters
|
|
386
DELISTED
Pioneer Natural Resource Co.
PXD
| $179M | 0.04% |
1,026,609
+65,096
| +7% | +$11.6M |
2013 Q2
21 quarters
|
|
387
Vanguard FTSE Pacific ETF
VPL
$8.94B
| $178M | 0.04% |
2,505,045
-26,707
| -1% | -$1.86M |
2013 Q2
21 quarters
|
|
388
XPO
XPO
$21.5B
| $178M | 0.04% |
4,502,305
+1,502,232
| +50% | +$54.6M |
2013 Q2
21 quarters
|
|
389
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.17B
| $176M | 0.04% |
4,611,579
+664,223
| +17% | +$25.7M |
2013 Q2
21 quarters
|
|
390
Zillow
ZG
$6.72B
| $175M | 0.04% |
3,965,989
+2,201,039
| +125% | +$115M |
2013 Q2
21 quarters
|
|
391
Labcorp
LH
$25.3B
| $175M | 0.04% |
1,171,793
+276,937
| +31% | +$42.1M |
2013 Q2
21 quarters
|
|
392
First Trust Europe AlphaDEX Fund
FEP
$503M
| $175M | 0.04% |
4,570,757
-42,837
| -0.9% | -$1.66M |
2013 Q2
21 quarters
|
|
393
International Paper
IP
$17B
| $174M | 0.04% |
3,740,768
+300,777
| +9% | +$14.9M |
2013 Q2
21 quarters
|
|
394
Travelers Companies
TRV
$76.9B
| $174M | 0.04% |
1,338,208
-78,778
| -6% | -$10.2M |
2013 Q2
21 quarters
|
|
|
AABA
395
DELISTED
Altaba Inc
AABA
| $174M | 0.04% |
2,548,105
+518,394
| +26% | +$36.5M |
2017 Q2
5 quarters
|
|
|
MMP
396
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $173M | 0.04% |
2,555,230
-171,263
| -6% | -$11.9M |
2013 Q2
21 quarters
|
|
397
Exelon
EXC
$43B
| $171M | 0.04% |
5,503,059
+1,289,083
| +31% | +$39.7M |
2013 Q2
21 quarters
|
|
398
iShares Semiconductor ETF
SOXX
$46.3B
| $171M | 0.04% |
2,775,750
+1,020,684
| +58% | +$63M |
2013 Q2
21 quarters
|
|
399
Marsh
MRSH
$83.9B
| $171M | 0.04% |
2,069,115
+320,959
| +18% | +$27.2M |
2013 Q2
21 quarters
|
|
400
Lam Research
LRCX
$399B
| $171M | 0.04% |
11,278,010
-4,023,190
| -26% | -$68.7M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.